Symbios has protected its inventions and technologies by filing six patent applications, with the core technology being protected under U.S. Patent 9,346,691, issued May 24, 2016.
For healthcare applications, Symbios has been awarded two additional patents in 2020 and 2023 .
As new intellectual property is developed through the engineering and commercialization process, the company’s patent strategy will be implemented and additional patents filed.